Publikationen
-
Image|01. 07. 2012
Speed-Up, Scale Up: Strategies, tools and policies to get the best HIV treatment to more people, sooner
This report outlines some of the strategies, tools and policies that have supported the scaling up of treatment during the past decade as well as those that can address persistent or new challenges. The results are presented from a 23-country survey of how consistently these strategies are being implemented.
-
Image|10. 07. 2012
Closer to Home - Delivering Antiretroviral Therapy in the Community: Experience from four Countries in Southern Africa
This document shows how health programmes can be designed to deliver antiretroviral drugs at a communits level.
-
Image|01. 07. 2012
Untangling the Web of Antiretroviral Price Reductions, 15th Edition – July 2012
The 15th edition of this publication gives an overview on drug prices and their quality, introduces the main actors in the field and the threats and challenges in keeping the prices of ARVs down.
-
Image|17. 09. 2012
Uncounted and untreated: Children with Tuberculosis, Fact Sheet
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘lowlights’—that have occurred over the last year.
-
Image|13. 09. 2012
“Out of the dark: Meeting the needs of children with tuberculosis”, Update of Report
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘lowlights’—that have occurred over the last year.
-
Image|27. 10. 2004
Patentschutz und die Zukunft des Medikamentenzugangs in ärmeren Ländern
Normal 0 21 false false false DE X-NONE X-NONE
Aktuelle Entwicklungen im weltweiten Patentrecht verschärfen das Problem des Zugangs zu bezahlbaren Medikamenten
/* Style Definitions */ table.MsoNormalTable {mso-style-name:"Normale Tabelle"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin;}
-
Image|16. 03. 2005
Running out of breath? TB care in the 21st century
-
Image|04. 09. 2003
Providing HIV Services including Antiretroviral Therapy at Primary Health Care Clinics in Resource-Poor Settings: The experience from Khayelitsha. (2003)
This report aims to inform and help ARV treatment programmes procure low-cost, quality ARVs effectively and efficiently.
-
Image|05. 09. 2003
"Trading away health" (2003), Intellectual Property and Access to Medicines in the Free Trade Area of the Americas (FTAA) Agreement
The HIV/AIDS crisis and the significant disparities in access to AIDS treatment between rich and poor countries provide a striking example of what is at stake in FTAA negotiations for people in the Americas.
-
Image|25. 04. 2004
Fact Sheet Malaria: Facts and Figures
This document provides the most important facts and figures on malaria.